Clinical Trial Update: Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SCH 497079 for weight reduction in obesity and overweight individuals has completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• SCH 497079

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED | Results posted: 2016-10-27